Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), today announced the continued expansion of its dried flower portfolio with the launch of four new large format offerings under its everyday cannabis brand Divvy. The new products strengthen the existing Divvy portfolio following a successful launch in Ontario’s adult-use market. The new large format offerings include 14 gram pouches and 10 gram pre-milled flower for added consumer convenience.

The Divvy brand targets the important dried flower and pre-roll market, which represented 70 per cent of total legal cannabis sales during the three months ended December 31, 2020, according to data from the Ontario Cannabis Store.

The 14-gram pouches feature Divvy’s signature THC strain Sour Kush, and the newly launched sativa-leaning cultivar Flo. Flo’s high-potency and unique terpene profile makes it a highly sought after cultivar not yet available in the legal Canadian cannabis market. It is the first new strain brought to market as part of the Company’s extensive new genetic research and development program. The 10-gram pre-milled offering includes two initial SKUs featuring either select indica or sativa-dominant cultivars.

“The Divvy brand is making waves in the all-important dried flower and pre-roll categories by offering outstanding product quality and accessible pricing for cannabis consumers. Backed by outstanding feedback from customers and strong early sales, we are delighted to secure provincial listings for our large format offerings,” said Aleafia Health CEO Geoffrey Benic.

Divvy, part of the Sunday Market brand family, features five distinct brands with differentiated products tailored to specific consumer segments. Divvy leverages Aleafia Health’s core competitive advantage of low-cost cultivation both at its Niagara Greenhouse facility and Port Perry outdoor cultivation facility. The new SKUs will be first available in Alberta, with expected roll-out to additional provinces.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
This email address is being protected from spambots. You need JavaScript enabled to view it.
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.